|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Ossur hf. (ICEX: OSSR), leading global supplier of prosthetic and orthopedic devices. |
|---|---|
| Transferring Party | Innovative Medical Products Holdings Ltd., a U.K. producer and distributor of knee, hip and spinal braces. |
| Sector | Medical Devices |
| Date | December 1, 2005 |
| Analysis Benefits of this $18.5 million acquisition include: (a) the integration of a strong U.K. sales network; (b) the enhancement of a sales network throughout Europe; and (c) the addition of Medistox and Technology in Motion brands. IMP had 91 employees, sales of about $14 million (1.24x) and EBITDA of approx. $2.70m (6.8x). | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |